Denne ordlyd var baseret på resultaterne af to randomiserede, kontrollerede forsøg med atorvastatin, 10 mg, til primær forebyggelse af kardiovaskulær sygdom.
This wording was based on the results of 2 randomised controlled trials performed with atorvastatin 10 mg for the primary prevention of cardiovascular disease (CVD).